Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

4-1BBL / CD137L / TNFSF9 Antikörper ( FITC )

Sino Biological Inc. liefert 4-1BBL / CD137L / TNFSF9 Antikörper ( FITC ) mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über 4-1BBL / CD137L / TNFSF9 Antikörper ( FITC ) lesen Sie bitte: http://www.sinobiological.com/4-1BBL-CD137L-TNFSF9-Antibody-g-10071.html

Produkt-Information von 4-1BBL / CD137L / TNFSF9 Antikörper

Immunogen

Recombinant Mouse 4-1BBL / CD137L / TNFSF9 protein (Catalog#50067-M07H)

Reagents FITC-conjugated rabbit monoclonal antibody

Clone ID

014

Ig Type

Rabbit IgG

Concentration

5 μl/Test, 0.2 mg/ml

Formulation Aqueous solution containing 0.5% BSA and 0.1% sodium azide
Preparation

This antibody was obtained from a rabbit immunized with purified, recombinant Mouse 4-1BBL / CD137L / TNFSF9 (rM 4-1BBL / CD137L / TNFSF9; Catalog#50067-M07H; NP_033430.1; Arg 104-Glu 309) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.

Usage Guide von 4-1BBL / CD137L / TNFSF9 Antikörper

Specificity

Mouse 4-1BBL / CD137L / TNFSF9

Flow Cytometry
4-1BBL / CD137L / TNFSF9 Flow Cytometry

Profile of anti-TNFSF9 reactivity on Raw264.7 cells analyzed by flow cytometry. Cells should be Fc-blocked by treatment with Mouse BD Fc Block™ purified anti-CD16/CD32 mAb 2.4G2 (Cat. No. 553141) prior to staining, washed, then stained with FITC Rabbit anti-TNFSF9.

Flow cytometry was performed on a BD FACSCalibur flow cytometry system

Please refer to www.sinobiological.com/Flow-Cytometry-FACS-Protocols-a-750.html for technical protocols.

Storage This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

Verwandte Produkte & Themen von 4-1BBL / CD137L / TNFSF9 Antikörper

Related Areas:

Immunology>>Adaptive Immunity>>Costimulation & Costimulatory Molecule>>4-1BBL/CD137L/TNFSF9

Immunology>>Cytokine & Receptor>>TNF Superfamily>>4-1BBL/CD137L/TNFSF9

Immunology>>Cluster of Differentiation>>B Cell CD Antigen>>4-1BBL/CD137L/TNFSF9

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
4-1BBL/CD137L Mouse 4-1BBL/CD137L Protein, Recombinant 50067-M07H
4-1BBL/CD137L Rat TNFSF9 Protein, Recombinant 80166-R01H
4-1BBL/CD137L Rat TNFSF9 Protein, Recombinant 80166-R07H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Mouse
4-1BBL/CD137L
WB, ELISA Rabbit Monoclonal Antibody 50067-R014
Mouse
4-1BBL/CD137L
FCM 4-1BBL / CD137L / TNFSF9 Antibody ( FITC ) 50067-R014-F
Mouse
4-1BBL/CD137L
ELISA Rabbit Polyclonal Antibody 50067-RP01
Mouse
4-1BBL/CD137L
WB, ELISA Rabbit Polyclonal Antibody 50067-RP02

Hintergrund von 4-1BBL / CD137L / TNFSF9 Antikörper

4-1BB ligand (4-1BBL), also known as TNFSF9, is a member of the tumor necrosis factor (TNF) superfamily (TNFSF), and interacts with 4-1BB (CDw137) expressed on activated T cells and delivers a costimulatory signal for T cell activation and growth. Mouse 4-1BBL is a 309 amino acid (aa) residues protein with an 82 aa N-terminal cytoplasmic domain, a 21 aa transmembrane domain and a 206 aa C-terminal extracellular domain. The extracellular domain of 4-1BBL has a tertiary structure similar to that other TNFSF members, but shares only low aa sequence homology (14 - 16%). Murine 4-1BBL shares 36% aa sequence identity with its human counterpart which is detected in both T and B cells of human peripheral blood. 4-1BB ligand interacts with 4-1BB and co-stimulates the latter to secrete cytokines and to proliferate, and also this interaction modulates the effector CD4+ T cell-driven immune response and cytokine production in colitis without affecting regulatory T cell function.

References

  1. Goodwin, R.G. et al., 1993, Eur. J. Immunol. 23: 2631-2641.
  2. Alderson, M.R. et al., 1994, Eur. J. Immunol. 24: 2219-2227.
  3. Zhou, Z.et al., 1995, Immunol. Lett. 45 (1-2): 67-73.
  4. Futagawa, T. et al., 2002, Int Immunol. 14 (3): 275-286.
  5. Yoshida,H. et al., 2003, Cancer Immunol Immunother.52 (2): 97-106.
  6. Maerten, P. et al., 2006, Clin Exp Immunol.143 (2): 228-236.

Primary Antibody Products

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post